Allergan to buy SkinMedica for $350 million
Allergan Inc. said it agreed to buy SkinMedica Inc.'s topical-aesthetics skin-care business for $350 million to increase its presence in the skin-care market.
Allergan Inc., the Irvine-based maker of Botox and other drugs, said Monday it would spend $60 million to buy co-promotion rights for a migraine headache drug from a Bay Area drug maker.